Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Expert Opinion on Drug Safety|April 11, 2017
The safety of extended-release drug formulations for the treatment of ADHDAnn ChildressExpert Opinion on Pharmacotherapy|May 21, 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulantsAnn ChildressExpert Opinion on Drug Safety|October 16, 2023
An updated safety review of the current drugs for managing ADHD in childrenErika Ryst, Ann ChildressExpert Opinion on Drug Metabolism & Toxicology|July 18, 2022
Evaluating the pharmacokinetics of extended release viloxazine in the treatment of children with attention-deficit/hyperactivity disorderAnn Childress, Shelby BurtonExpert Opinion on Investigational Drugs|January 28, 2016
Current Investigational Drugs for the Treatment of Attention-Deficit/Hyperactivity DisorderAnn Childress, Chau TranExpert Review of Neurotherapeutics|April 17, 2024
A critical review of the dextroamphetamine transdermal system for the treatment of ADHD in adults and pediatric patientsAnn Childress, Nicolas VaughnExpert Opinion on Investigational Drugs|September 9, 2014
Pozanicline for the treatment of attention-deficit/hyperactivity disorderAnn Childress, Floyd R SalleeExpert Review of Neurotherapeutics|September 24, 2013
The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHDAnn Childress, Floyd R SalleeExpert Review of Neurotherapeutics|October 17, 2023
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patientsAnn Childress, Robert Sottile, Sherine KhanbijianAdvances in Therapy|May 23, 2026
The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents: A Systematic Review and Meta-AnalysisAnn Childress, Hirah Malik, Jim PotenzianoPageof 8